✦ LIBER ✦

Surface-specific effects of a PPARγ agonist, darglitazone, on bone in mice

✍ Scribed by M. Li; L.C. Pan; H.A. Simmons; Y. Li; D.R. Healy; B.S. Robinson; H.Z. Ke; T.A. Brown

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antidiabetic effect of a novel non-thiaz

✍ Xi HU; Ying FENG; Yu SHEN; Xiao-feng ZHAO; Juan-hong YU; Yu-she YANG; Ying LENG 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 Chinese ⚖ 343 KB

Effects of rosiglitazone, a PPAR-γ agoni

✍ A. RIZZO; M. SPEDICATO; C. COSOLA; G. MINOIA; M. T. ROSCINO; S. PUNZI; R. L. SCI 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Additive renoprotective effects of B2-ki

✍ Tang, Sydney C W; Chan, Loretta Y Y; Leung, Joseph C K; Cheng, Amy Shan; Lan, Hu 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 822 KB

Effects of bezafibrate, PPAR pan-agonist

✍ Tatsuya Nagasawa; Yoichi Inada; Shigeru Nakano; Toru Tamura; Tetsuaki Takahashi; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 946 KB

A novel peroxisome proliferator-activate

✍ Takashi Yotsumoto; Takeshi Naitoh; Tatsuro Kanaki; Maho Matsuda; Nobutomo Tsuruz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Effects of cevoglitazar, a dual PPARα/γ

✍ D. Laurent; J. S. Gounarides; J. Gao; B. R. Boettcher 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB